Trinity Biotech R&D Spending Growth & History (TRIB)
Trinity Biotech's r&d spending was $3.6M for fiscal 2025.
View full Trinity Biotech company overviewTrinity Biotech annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.6M | −$914,000 | −20.12% |
| 2024 | 2024-12-31 | $4.5M | $164,000 | +3.75% |
| 2023 | 2023-12-31 | $4.4M | $241,000 | +5.82% |
| 2022 | 2022-12-31 | $4.1M | −$359,000 | −7.98% |
| 2021 | 2021-12-31 | $4.5M | −$583,000 | −11.48% |
| 2020 | 2020-12-31 | $5.1M | −$245,000 | −4.60% |
| 2019 | 2019-12-31 | $5.3M | −$44,000 | −0.82% |
| 2018 | 2018-12-31 | $5.4M | −$288,000 | −5.09% |
| 2017 | 2017-12-31 | $5.7M | $617,000 | +12.24% |
| 2016 | 2016-12-31 | $5.0M | −$29,000 | −0.57% |
| 2015 | 2015-12-31 | $5.1M | — | — |
Trinity Biotech quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $1.5M | — | — |
| Q2 2018 | 2018-06-30 | $1.4M | $97,000 | +7.34% |
| Q2 2017 | 2017-06-30 | $1.3M | — | — |
Trinity Biotech r&d spending trends
Over the last five fiscal years, Trinity Biotech's r&d spending decreased from $5.1M to $3.6M, a change of −$1.5M. The latest reported quarter, Q4 2024, shows $1.5M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗